CN115429846A - Medicine for preventing and treating cataract and myopia and its preparing method - Google Patents
Medicine for preventing and treating cataract and myopia and its preparing method Download PDFInfo
- Publication number
- CN115429846A CN115429846A CN202110606014.8A CN202110606014A CN115429846A CN 115429846 A CN115429846 A CN 115429846A CN 202110606014 A CN202110606014 A CN 202110606014A CN 115429846 A CN115429846 A CN 115429846A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- microalgae
- water
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 208000002177 Cataract Diseases 0.000 title claims abstract description 27
- 230000004379 myopia Effects 0.000 title claims abstract description 24
- 208000001491 myopia Diseases 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 13
- 229940079593 drug Drugs 0.000 title description 10
- 239000000284 extract Substances 0.000 claims abstract description 73
- 239000003889 eye drop Substances 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000000463 material Substances 0.000 claims abstract description 28
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 16
- 239000003906 humectant Substances 0.000 claims abstract description 16
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 16
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 16
- 239000008367 deionised water Substances 0.000 claims abstract description 15
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 13
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 13
- 229940082787 spirulina Drugs 0.000 claims abstract description 13
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 11
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 10
- 241000195633 Dunaliella salina Species 0.000 claims abstract description 10
- 235000021466 carotenoid Nutrition 0.000 claims description 42
- 150000001747 carotenoids Chemical class 0.000 claims description 42
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 34
- -1 chlorophyll ester Chemical class 0.000 claims description 27
- 240000005546 Piper methysticum Species 0.000 claims description 25
- 235000016787 Piper methysticum Nutrition 0.000 claims description 25
- 241000219357 Cactaceae Species 0.000 claims description 22
- 238000004821 distillation Methods 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 17
- 108010053210 Phycocyanin Proteins 0.000 claims description 16
- 239000011259 mixed solution Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 229930002875 chlorophyll Natural products 0.000 claims description 15
- 235000019804 chlorophyll Nutrition 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 240000008574 Capsicum frutescens Species 0.000 claims description 14
- 241000967218 Selaginella tamariscina Species 0.000 claims description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 241000746375 Andrographis Species 0.000 claims description 13
- 230000003020 moisturizing effect Effects 0.000 claims description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 12
- 229940116229 borneol Drugs 0.000 claims description 12
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 12
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 12
- 235000011477 liquorice Nutrition 0.000 claims description 12
- 235000002568 Capsicum frutescens Nutrition 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 11
- 244000234609 Portulaca oleracea Species 0.000 claims description 10
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 10
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 241000212322 Levisticum officinale Species 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000001645 levisticum officinale Substances 0.000 claims description 7
- 239000000314 lubricant Substances 0.000 claims description 7
- 229910001220 stainless steel Inorganic materials 0.000 claims description 7
- 239000010935 stainless steel Substances 0.000 claims description 7
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000009792 diffusion process Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims description 4
- 240000009108 Chlorella vulgaris Species 0.000 claims description 4
- 235000007089 Chlorella vulgaris Nutrition 0.000 claims description 4
- 238000005292 vacuum distillation Methods 0.000 claims description 4
- 241000195634 Dunaliella Species 0.000 claims description 3
- 241000244365 Ligusticum sinense Species 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- 150000001746 carotenes Chemical class 0.000 claims description 2
- 235000005473 carotenes Nutrition 0.000 claims description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 2
- 210000003298 dental enamel Anatomy 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 2
- 244000004281 Eucalyptus maculata Species 0.000 claims 2
- 240000002948 Ophiopogon intermedius Species 0.000 claims 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 35
- 210000004369 blood Anatomy 0.000 abstract description 30
- 239000008280 blood Substances 0.000 abstract description 30
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 230000004438 eyesight Effects 0.000 abstract description 12
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 7
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 208000010412 Glaucoma Diseases 0.000 abstract description 5
- 208000034699 Vitreous floaters Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 5
- 241000909851 Epiphora Species 0.000 abstract description 3
- 208000003464 asthenopia Diseases 0.000 abstract description 3
- 208000016747 lacrimal apparatus disease Diseases 0.000 abstract description 3
- 241000475481 Nebula Species 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 description 50
- 229940012356 eye drops Drugs 0.000 description 27
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 19
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 19
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 15
- 150000003254 radicals Chemical class 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 244000166124 Eucalyptus globulus Species 0.000 description 12
- 206010042674 Swelling Diseases 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 244000248557 Ophiopogon japonicus Species 0.000 description 11
- 235000008216 herbs Nutrition 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000002566 Capsicum Nutrition 0.000 description 8
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 208000014674 injury Diseases 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 208000019901 Anxiety disease Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- XEAQIWGXBXCYFX-GUOLPTJISA-N Kawain Chemical compound C1C(OC)=CC(=O)O[C@H]1\C=C\C1=CC=CC=C1 XEAQIWGXBXCYFX-GUOLPTJISA-N 0.000 description 6
- 230000036506 anxiety Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 244000118350 Andrographis paniculata Species 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 4
- 241000195628 Chlorophyta Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241000168525 Haematococcus Species 0.000 description 4
- 208000006877 Insect Bites and Stings Diseases 0.000 description 4
- 241000270295 Serpentes Species 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000004078 Snake Bites Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000013793 astaxanthin Nutrition 0.000 description 4
- 239000001168 astaxanthin Substances 0.000 description 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 4
- 229940022405 astaxanthin Drugs 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 235000017663 capsaicin Nutrition 0.000 description 4
- 229960002504 capsaicin Drugs 0.000 description 4
- 230000001886 ciliary effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 206010023332 keratitis Diseases 0.000 description 4
- 239000002858 neurotransmitter agent Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 235000015961 tonic Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 229960000716 tonics Drugs 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 241000192700 Cyanobacteria Species 0.000 description 3
- VOOYTQRREPYRIW-LBPRGKRZSA-N Dihydrokavain Chemical compound C1C(OC)=CC(=O)O[C@H]1CCC1=CC=CC=C1 VOOYTQRREPYRIW-LBPRGKRZSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 239000006002 Pepper Substances 0.000 description 3
- 241000722363 Piper Species 0.000 description 3
- 235000016761 Piper aduncum Nutrition 0.000 description 3
- 235000017804 Piper guineense Nutrition 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000000695 crystalline len Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- XEAQIWGXBXCYFX-UHFFFAOYSA-N dl-kavain Natural products C1C(OC)=CC(=O)OC1C=CC1=CC=CC=C1 XEAQIWGXBXCYFX-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 150000002559 kavalactones Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- JVKYZPBMZPJNAJ-OQFNDJACSA-N 22R,25S-Solanidine Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H]3N4C[C@@H](C)CC[C@@H]4[C@@H](C)[C@@H]3[C@@]1(C)CC2 JVKYZPBMZPJNAJ-OQFNDJACSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- PGCKDCPTJAQQSQ-UHFFFAOYSA-N Isolicoflavonol Chemical compound C1=C(O)C(CC=C(C)C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 PGCKDCPTJAQQSQ-UHFFFAOYSA-N 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- GTEXBOVBADJOQH-FWEMWIAWSA-N Methysticin Chemical compound C1C(OC)=CC(=O)O[C@H]1\C=C\C1=CC=C(OCO2)C2=C1 GTEXBOVBADJOQH-FWEMWIAWSA-N 0.000 description 2
- CGGHGWCWEAXPLK-CYBMUJFWSA-N Methysticin Natural products CC(=O)C1=CC(=O)O[C@@H](C1)C=Cc2ccc3OCOc3c2 CGGHGWCWEAXPLK-CYBMUJFWSA-N 0.000 description 2
- BBYSWXUKFBVXAO-UHFFFAOYSA-N Ophiopogonone A Chemical compound C1=C2OCOC2=CC(CC2=COC3=CC(O)=C(C(=C3C2=O)O)C)=C1 BBYSWXUKFBVXAO-UHFFFAOYSA-N 0.000 description 2
- 235000004727 Opuntia ficus indica Nutrition 0.000 description 2
- 240000009297 Opuntia ficus-indica Species 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000758706 Piperaceae Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010038084 Rectocele Diseases 0.000 description 2
- PQUOYNVEQWXFHJ-UHFFFAOYSA-N Solanidin Natural products CC1CCC2C(C)C3(C)C4CCC5C(CC=C6CC(O)CCC56C)C4CC3N2C1 PQUOYNVEQWXFHJ-UHFFFAOYSA-N 0.000 description 2
- JVKYZPBMZPJNAJ-LZQZKFTPSA-N Solanidine Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@@H]5[C@@H](C)[C@H]6N([C@@H]5C4)C[C@H](C)CC6)CC3)CC=2)CC1 JVKYZPBMZPJNAJ-LZQZKFTPSA-N 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010070863 Toxicity to various agents Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- RXVGBQCEAQZMLW-UHFFFAOYSA-N alpha-solanine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7OC9OC(CO)C(O)C(O)C9O)N2C1 RXVGBQCEAQZMLW-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 201000009310 astigmatism Diseases 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000010515 dystocia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940107491 kava root Drugs 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000000820 nonprescription drug Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 230000004436 pseudomyopia Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- VBTSYRNFJCJUHA-UHFFFAOYSA-N solanidine Natural products C1CC2(C)C3CCC4(C)C5C(C)C6CCC(C)CN6C5CC4C3CC=C2CC1OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(CO)C(O)C(O)C1O VBTSYRNFJCJUHA-UHFFFAOYSA-N 0.000 description 2
- ZGVSETXHNHBTRK-OTYSSXIJSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-OTYSSXIJSA-N 0.000 description 2
- 229940031352 solanine Drugs 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- MPDGHEJMBKOTSU-WFJWTYAKSA-N (2s,4as,6as,6br,10s,12as)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid Chemical compound C12C(=O)C=C3C4C[C@@](C)(C(O)=O)CC[C@]4(C)CC[C@@]3(C)[C@]1(C)CCC1[C@]2(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-WFJWTYAKSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- GVOIABOMXKDDGU-XRODXAHISA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Chemical compound O=C([C@@]1(C)C(C[C@H](O)C1)(C)C)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C GVOIABOMXKDDGU-XRODXAHISA-N 0.000 description 1
- GVOIABOMXKDDGU-LOFNIBRQSA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)C1(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C GVOIABOMXKDDGU-LOFNIBRQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KKSCKZFKHNHGEO-UHFFFAOYSA-N 24-methylenecycloartanol Natural products CC(CCC(=C)C(C)(C)O)C1CCC2C3CCC4C(C)(C)C(O)CCC45CC35CCC12C KKSCKZFKHNHGEO-UHFFFAOYSA-N 0.000 description 1
- XZEUYTKSAYNYPK-UHFFFAOYSA-N 3beta-29-Norcycloart-24-en-3-ol Natural products C1CC2(C)C(C(CCC=C(C)C)C)CCC2(C)C2CCC3C(C)C(O)CCC33C21C3 XZEUYTKSAYNYPK-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010049589 Afterbirth pain Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 201000002045 Ancylostomiasis Diseases 0.000 description 1
- 208000033211 Ankylostomiasis Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 1
- GVOIABOMXKDDGU-SUKXYCKUSA-N Capsorubin Natural products O=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)[C@@]1(C)C(C)(C)C[C@H](O)C1)\C)/C)\C)/C)[C@@]1(C)C(C)(C)C[C@H](O)C1 GVOIABOMXKDDGU-SUKXYCKUSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 241000195627 Chlamydomonadales Species 0.000 description 1
- 241000196319 Chlorophyceae Species 0.000 description 1
- 241000755726 Chlorophytum Species 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- RRTBTJPVUGMUNR-UHFFFAOYSA-N Cycloartanol Natural products C12CCC(C(C(O)CC3)(C)C)C3C2(CC)CCC2(C)C1(C)CCC2C(C)CCCC(C)C RRTBTJPVUGMUNR-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 1
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020376 Hookworm infection Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 240000001812 Hyssopus officinalis Species 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- DHHFDKNIEVKVKS-RYGANQNKSA-N Isobetanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C/1C=C(C(O)=O)N[C@@H](C(O)=O)C\1 DHHFDKNIEVKVKS-RYGANQNKSA-N 0.000 description 1
- HVXLSFNCWWWDPA-UHFFFAOYSA-N Isocycloartenol Natural products C1CC(O)C(C)(C)C2C31CC13CCC3(C)C(C(CCCC(C)=C)C)CCC3(C)C1CC2 HVXLSFNCWWWDPA-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 241000169546 Lycium ruthenicum Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- KSIVGTKSVYIZEB-GDUJLLAZSA-N Ophiopogonin A Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]1O[C@@H]1C[C@H](O)CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](OC(C)=O)[C@H]1O KSIVGTKSVYIZEB-GDUJLLAZSA-N 0.000 description 1
- HGHDGOQXDUNVGT-UHFFFAOYSA-N Ophiopogonin B Natural products CC1CCC2(OC1)OC3CC4C5CC=C6CCCC(OC7OC(C)C(O)C(O)C7OC8OC(C)C(O)C(O)C8O)C6(C)C5CCC4(C)C3C2C HGHDGOQXDUNVGT-UHFFFAOYSA-N 0.000 description 1
- OWGURJWJHWYCIQ-AKYREZHBSA-N Ophiopogonin B Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]1O[C@@H]1C[C@H](O)CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O OWGURJWJHWYCIQ-AKYREZHBSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000813872 Oscillatoriaceae Species 0.000 description 1
- 241001469893 Oxyzygonectes dovii Species 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 241000070023 Phoenicopterus roseus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- HXQRIQXPGMPSRW-UHZRDUGNSA-N Pollinastanol Natural products O[C@@H]1C[C@H]2[C@@]3([C@]4([C@H]([C@@]5(C)[C@@](C)([C@H]([C@H](CCCC(C)C)C)CC5)CC4)CC2)C3)CC1 HXQRIQXPGMPSRW-UHZRDUGNSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000353135 Psenopsis anomala Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000037169 Retrograde Degeneration Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 1
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- KVQOADNSNSUAJT-NHULGOKLSA-N alpha-Patchoulene Natural products C[C@@H]1[C@H]2[C@]3(C(C)(C)[C@H](C2)CC=C3C)CC1 KVQOADNSNSUAJT-NHULGOKLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 210000002937 blood-testis barrier Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 235000009132 capsorubin Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052878 cordierite Inorganic materials 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- ONQRKEUAIJMULO-YBXTVTTCSA-N cycloartenol Chemical compound CC(C)([C@@H](O)CC1)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@@H](CCC=C(C)C)C)CC[C@@]3(C)[C@@H]1CC2 ONQRKEUAIJMULO-YBXTVTTCSA-N 0.000 description 1
- YNBJLDSWFGUFRT-UHFFFAOYSA-N cycloartenol Natural products CC(CCC=C(C)C)C1CCC2(C)C1(C)CCC34CC35CCC(O)C(C)(C)C5CCC24C YNBJLDSWFGUFRT-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-UHFFFAOYSA-N cycloartenol trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OC2C(C3CCC4C5(C)CCC(C5(C)CCC54CC53CC2)C(C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-UHFFFAOYSA-N 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- VOOYTQRREPYRIW-UHFFFAOYSA-N dihydrokawain Natural products C1C(OC)=CC(=O)OC1CCC1=CC=CC=C1 VOOYTQRREPYRIW-UHFFFAOYSA-N 0.000 description 1
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 235000017088 isobetanin Nutrition 0.000 description 1
- CTMLKIKAUFEMLE-RYGANQNKSA-N isobetanin Natural products OC[C@H]1O[C@@H](Oc2cc3C[C@H](N(C=CC4=CC(=N[C@H](C4)C(=O)O)C(=O)O)c3cc2O)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O CTMLKIKAUFEMLE-RYGANQNKSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- KSIVGTKSVYIZEB-UHFFFAOYSA-N lirioplioside B Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C45C)C)C1CC2C3CC=C4CC(O)CC5OC1OC(C)C(O)C(O)C1OC1OC(C)C(O)C(OC(C)=O)C1O KSIVGTKSVYIZEB-UHFFFAOYSA-N 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229940109990 ruscogenin Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229940095110 selaginella tamariscina extract Drugs 0.000 description 1
- 201000008525 senile cataract Diseases 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 235000003724 spirulina extract Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- KVQOADNSNSUAJT-UHFFFAOYSA-N α-patchoulene Chemical compound CC1=CCC(C2(C)C)CC3C12CCC3C KVQOADNSNSUAJT-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-PMTKVOBESA-N β-glycyrrhetinic acid Chemical compound C([C@@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-PMTKVOBESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Abstract
A medicine for preventing and treating cataract and myopia is prepared from water-soluble extract and oil-soluble extract of microalgae (including Dunaliella salina, chlorella, haematococcus pluvialis, and Spirulina) or similar composition, and Chinese medicinal materials including rhizoma Ligustici Chuanxiong extract, herba Andrographitis extract, radix et caulis Opuntiae Dillenii extract, glycyrrhrizae radix extract, radix Ophiopogonis extract, herba Portulacae extract, herba Selaginellae extract, capsici fructus extract, folium Eucalypti Globueli extract, fructus Piperis extract, borneolum Syntheticum extract, sodium hyaluronate, polyethylene glycol, humectant, and deionized water. The eye drop prepared by the method has no side effect, has the effects of clearing heat, reducing internal heat, detoxifying, resisting inflammation, improving eyesight, removing nebula, promoting blood circulation and removing blood stasis, and has good effects on treating myopia, cataract, muscae volitantes, epiphora induced by wind, asthenopia and glaucoma.
Description
Technical Field
The invention relates to an eye drop, in particular to a medicine for preventing and treating cataract and myopia and a preparation method thereof.
Background
With the increasing aging population and the difference of living habits and environments of modern people, the eyes are excessively used for a long time by computers, mobile phones, books or other eyes, and more importantly, the living environment with high pressure for a long time, so that ciliary muscles, crystalline lenses, eyeballs, peripheral capillaries, nerves and the like of the eyes are easy to generate a large amount of enriched free radicals, and eye diseases such as myopia or cataract, glaucoma, muscae volitantes and the like occur. The old people are caused by falling injury with various diseases due to vision loss. According to the records of related documents, the myopia and cataract of the agricultural era are found to be obviously less than those of the existing industrial era, especially the modern industry and information technology cannot be separated from mobile phones and computers, the working time is long, and the eyes are used excessively; this is the root cause of myopia and cataract in modern people. Numerous medical studies and clinical trials have demonstrated that free radical damage to human cells is a source of ten thousand diseases. A radical is a species lacking electrons (unsaturated electron species). Free radicals compete for electrons of human cells throughout the human body, and if electrons of cellular protein molecules are deprived, proteins are connected with branched chains to be alkylated, and malformed molecules are formed, so that various diseases of the human body can occur.
The existing common methods for treating eye diseases such as myopia, cataract and the like have modes of medicament treatment, operation treatment and the like, wherein the operation treatment has damage or sequelae on a human body and has certain risk; however, most of the existing drug therapies adopt atropine eyedrops or eye ointments, but the effect is not obvious, the preparation process is unstable, and a large amount of free radicals such as eyeballs, peripheral capillaries and nerves are difficult to eliminate. In order to eliminate a large amount of free radicals generated by overuse of eyes and environmental factors, according to the records of related data, blueberry, lycium ruthenicum mill, mulberry, vitamin E, vitamin C or high-efficiency substances containing selenium and the like for resisting free radicals have certain effects on myopia and cataract, but the effects are not obvious. The current therapy for treating the myopia mainly comprises laser beating or wearing myopia glasses. The aspect of medicine treatment is also disclosed in the literature, see the Chinese patent application of 201610878461.8 entitled "eyedrops for treating myopia and preparation method thereof" (publication number CN 106344733A); reference may also be made to the chinese invention patent application publication No. 201811596176.2, an eye drop for external use for improving myopia (publication No. CN 111346152A). The most important aspect of the long-term medical history in China is to pay attention to the relationship between eyes and viscera, meridians, qi, blood and body fluids when treating eye diseases. The Ling Shu & big Huo Lun: essential qi of five zang-organs and six fu-organs is the essence by injecting upward to the eyes. The seminal nest is the eye, the essence of bone is the pupil, the essence of tendon is the black eye, the essence of blood is the collateral, the essence of nest qi is the white eye, the essence of muscle is the restraint, it wraps up the essence of blood and qi of tendons and bones, and the blood and vessels are involved, and the above belongs to the brain and later comes out of the neck. The meridians and collaterals are the functions of circulating qi and blood throughout the body and communicating the exterior, interior and exterior, and connecting the zang-fu organs. Lingshu, the chapter of visceral manifestation with pathogenic factors: the blood and qi of the twelve main meridians, three hundred and six fifteen collaterals, all go up to the face to open orifices, and the essence and yang qi go up to the eyes to form essence. All this means that the eyes and zang-fu organs are connected through the meridians and collaterals, and they are in organic connection. The visual function of the eye is maintained only by the continuous transmission of blood and air through the meridians.
Therefore, the inventor thinks that the excessive eye and environmental factors and the functional aging meridian obstruction of modern people are the root causes causing the abundant accumulation of free radicals such as ciliary muscle, crystalline lens, eyeball and peripheral microvasculature and nerves. Furthermore, the excessive amount of free radicals can cause the fundamental causes of juvenile myopia, senile cataract, muscae volitantes, glaucoma and presbyopia just because the ciliary muscle of the eye can not stretch flexibly due to the abundant enrichment of the free radicals, the spasm of the eye and the peripheral muscle, the blockage of blood vessels, the lens can not obtain nutrition and the metabolic waste can not be discharged smoothly. The therapeutic medicine is prepared by combining Chinese medicine with western medicine. The invention was made.
Disclosure of Invention
The invention aims to solve the defects of the existing eye drops and provide a medicine for preventing and treating cataract and myopia and a preparation method thereof.
The invention realizes the purpose of a medicine for preventing and treating cataract and myopia and a preparation method thereof, and the medicine is prepared by matching a water-soluble extract and an oil-soluble extract of microalgae (comprising dunaliella salina, chlorella vulgaris, haematococcus pluvialis and spirulina) or similar compositions with a traditional Chinese medicine ligusticum chuanxiong hort extract, an andrographis paniculata extract, a large flower cactus extract, a liquorice extract, an ophiopogon root extract, a purslane extract, a selaginella tamariscina extract, a capsicum extract, a eucalyptus leaf extract, a kava extract, a borneol extract, sodium hyaluronate, polyethylene glycol, a humectant and deionized water. The microalgae oil-soluble extract is carotenoid, phycocyanin, chlorophyll ester and glycerate, the use amount of the microalgae oil-soluble extract in the eye drop is 0.01-100ppm, and PVP is added before use to make the fat-soluble carotenoid, phycocyanin ester, chlorophyll ester and glycerate 'dissolved' in water; the microalgae water soluble extract contains glycerol, vitamin C, vitamin B group, amino acids, etc. with concentration of 0.01-100ppm in eye drop, and can be mixed with oil soluble extract before use and directly dissolved in water; the dosage of each traditional Chinese medicine extract is 1-10%.
Further, sodium hyaluronate and polyethylene glycol are also included, and the sodium hyaluronate and the polyethylene glycol respectively account for 0.01 to 5 percent of the total weight.
Further, the sodium hyaluronate has a low molecular weight of 1000 daltons, and the polyethylene glycol is polyethylene glycol 400. The humectant is at least one of butanediol, glycerol, polyalcohol or propylene glycol.
A medicine for preventing and treating cataract and myopia is prepared through adding the solution of carotenoid extracted from microalgae (500-600 ppm) to deionized water (60-100 times of the said PVP), stirring to obtain the solution of carotenoid, and controlling the concentration of carotenoid in the eye solution to be less than 100ppm.
Further, adding sodium hyaluronate, chinese medicinal extract and polyethylene glycol, and stirring to obtain eye drop solution with sodium hyaluronate concentration of 0.01-100ppm; the dosage of the traditional Chinese medicine extract in the eye drops is 1-10%; the polyethylene glycol accounts for 0.01 to 1.5 percent of the total weight.
Furthermore, in the eye drops, the concentration of the microalgae extract carotenoid, phycocyanin ester, chlorophyll ester and glyceric acid lipid in the eye drops is 0.01ppm-100ppm, and the microalgae oil-soluble extract is added with PVP, a water-soluble extract and deionized water to prepare the eye drop microalgae extract. The microalgae extract is prepared from carotenoid, phycocyanin, chlorophyll ester or glycerate or synthetic carotenoid, chlorophyll ester, phycocyanin ester, glycerate water diffusion type dry powder and deionized water, wherein the content of active substances in the carotenoid, chlorophyll ester, phycocyanin ester and glycerate water diffusion type dry powder is 1-20%, and the concentration of the active substances in eye drops is 0.01-100ppm.
A medicine for preventing and treating cataract and myopia and a preparation method thereof,
the method is characterized by comprising the following steps:
(1) soaking the medicinal materials, wherein the medicinal materials with the following components and weight ratio are soaked by 1500-3000 parts of water by weight:
1 to 20 parts of ligusticum chuanxiong hort, 10 to 20 parts of common andrographis herb, 6 to 15 parts of large flower cactus, 6 to 15 parts of liquorice, 10 to 20 parts of dwarf lilyturf tuber, 6 to 15 parts of purslane, 6 to 15 parts of selaginella tamariscina, 1 to 20 parts of hot pepper, 1 to 20 parts of eucalyptus leaf, 1 to 20 parts of kava pepper and 0.1 to 3 parts of borneol; (2) vacuum distilling the above materials with a distilling device at vacuum degree of-0.2 MPA and distillation temperature of 60-80 deg.C to obtain white distilled extract; (3) adding 3-9 parts of humectant, 1 part of each of polyethylene glycol 400 and sodium hyaluronate 1000, and 1 part of microalgae carotene solution into the white distilled extract to obtain the eye drop. (4) Preparing water-soluble and oil-soluble microalgae extract, dissolving 2 parts of microalgae powder in 1000 parts of 95% alcohol, distilling at 50 ℃, vacuum pressure of-0.2 MPA, adding PVP aqueous solution into the distilled liquid, and the content of PVP is 30%; continuously heating the microalgae mixed solution added with PVP in vacuum for 30 minutes at the vacuum degree of-0.2 MPA and the temperature of 50 ℃, removing the organic solvent alcohol to obtain microalgae oil and water extract mixed solution, and measuring the content for later use. The eye drop is prepared by mixing the extracts of Chinese medicinal materials after measuring the contents of carotenoid, phycocyanin and chlorophyll ester, and bottling. (5) The microalgae extract water-soluble solution can also be prepared by mixing water-soluble diffusion dry powder of carotenoid, chlorophyll ester, phycocyanin ester and glyceric acid ester with deionized water; mixing with the prepared Chinese medicinal extract to make into eye drop.
The microalgae comprise: dunaliella, chlorella, haematococcus pluvialis, and Spirulina. These microalgae contain a large amount of oil-soluble antioxidants including carotenoids, phycocyanins, chlorophyll esters.
Dunaliella salina (Dunaliella salina), also known as "Dunaliella salina". Chlorophyceae, dunaliella family. One kind of salt tolerant unicellular eukaryon green algae. The alga body has no cell wall, large variation of body shape, pear shape, ellipse shape and the like, has two flagella with equal length and has a cup-shaped chromoplast in the body. Longitudinal fission or gametophy reproduction. Growing in seawater. Is rich in carotenoid. The glycerol or carotenoid can be extracted from the culture medium by artificial culture. And can be used as bait for fish, shrimp, shellfish, etc. Dunaliella salina is a unicellular eukaryotic alga which exists in a high-concentration salt lake and belongs to plankton. The vitamin C is the unique peculiar life which is discovered at present and can survive in high-concentration saline, is rich in various natural carotenoids, folic acid, vitamin A, vitamin E, linolenic acid, linoleic acid, lecithin, fucoidin, dietary fiber and the like which are required by human health, more than 70 mineral substances and trace elements which are required by human body such as calcium, iron, zinc, selenium and the like, and is also rich in 18 amino acids, wherein 8 amino acids are necessary for human body. Because the cell culture medium is rich in unique and abundant vital elements, the cell culture medium is praised as a cell power source and a life protective agent by the world scientific community.
Chlorella (Chlorella) is a kind of unicellular green algae of genus Chlorella of phylum Chlorophytum, and is a kind of spherical unicellular fresh water algae, the diameter is 3-8 microns, it is one of the earliest life on the earth, it appears 20 hundred million years ago, it is a kind of high-efficient photosynthetic plant, grow and reproduce by photoautotrophy, the distribution is extremely wide. Chlorella glycoprotein has antioxidant effect, and can scavenge free radicals in vivo. Free radicals are intermediate products of biochemical reactions in human life activities, and include superoxide anion free radical (O2 ·) and hydroxyl radical (· OH), among others.
Haematococcus is a kind of freshwater unicellular green algae belonging to Chlorophyta, volvocales, haematococcus and Haematococcus. The algae can accumulate a large amount of astaxanthin to show red color, so it is called Haematococcus pluvialis, also called Haematococcus pluvialis. Haematococcus is an algae food which is discovered in the scientific community at present and is rich in nutritional value and medicinal value after spirulina and chlorella vulgaris are processed. Astaxanthin is a red pigment which imparts a pink color to salmon, shrimp and flamingo. Its chemical structure is similar to that of beta-carotene (present in carrots) and vitamin a. Astaxanthin is part of the group of carotenoids. Natural astaxanthin is able to penetrate the three major human barriers blood-brain barrier, blood-pancreas barrier, blood-testis barrier and is the only carotenoid able to penetrate the blood-brain barrier and is therefore the only carotenoid likely to act on brain cells and the retina of the eye.
Spirulina (scientific name: spirulina) belongs to Cyanophyta, cyanophyceae, oscillatoriaceae, and Spirulina, is an ancient low-grade prokaryotic unicellular or multicellular aquatic plant, and has a length of 200-500 μm and a width of 5-10 μm. [1] Shaped like a clock spring, is spirally blue-green and is also called blue-green algae. The spirulina is rich in high-quality protein, fatty acid of gamma-linolenic acid, carotenoid, phycocyanin, vitamins, and various trace elements such as iron, iodine, selenium, zinc, etc.
Chuan Xiong is used for promoting blood circulation and moving qi, dispelling wind and relieving pain, and Chuan Xiong is warm, fragrant and dry, and can disperse and ascend to the vertex. Also enters blood system and descends to blood sea. Promoting blood circulation and removing blood stasis, it is suitable for various diseases due to blood stasis. Chuan Xiong can move qi and relieve depression, dispel wind-dryness and dampness, activate blood and alleviate pain. It is indicated for wind-cold headache, dizziness, hypochondriac pain, abdominal pain, cold arthralgia, spasm of tendons, amenorrhea, dystocia, postpartum pain due to blood stasis, carbuncle, cellulitis, sore and ulcer. Can be used for treating menoxenia, amenorrhea, dysmenorrhea, abdominal pain, pricking pain in chest and hypochondrium, traumatic injury, swelling and pain, headache, and rheumatalgia. Can be used for treating menoxenia, dysmenorrhea, amenorrhea, dystocia, lochiorrhea, puerperal lochiorrhea, abdominal pain, lump, chest and hypochondrium pain, traumatic injury, swelling and pain, headache, dizziness, dim eyesight, arthralgia due to wind-cold-dampness, numbness of limbs, superficial infection, and pyocutaneous disease.
The common andrographis herb is also known as: firstly, the raw materials are haplolic, the scabrous elephantfoot herb and the elegans, and the nature, taste and channel tropism are as follows: bitter taste and cold nature: it enters lung, heart, large intestine and bladder meridians. Lung heat and lung fire can be used.
Andrographis paniculata Nees has effects of clearing away heat and toxic materials, eliminating dampness and relieving swelling, and is good at treating swelling and pain of throat, cough and asthma, purulent phlegm, etc. caused by lung heat and lung fire. It can also be used for treating eczema and snake and insect bite. According to the records of Lingnan herbal medicine collection, andrographis paniculata Nees can relieve snake venom and treat internal injury and cough. According to records in Quanzhou materia Medica, creat clears away heat and toxic material, diminishes inflammation and subsides swelling, and treats inflammation of throat, dysentery and hyperpyrexia. Effective in clearing away heat and toxic material, eliminating dampness and relieving swelling. The main indications 1, the medicine is used for treating wind-heat common cold, the onset of pestilence, cough due to lung heat (including upper respiratory tract infection, pneumonia, bronchitis and the like), sore throat and the like. 2. Can be used for treating damp-heat dysentery, eczema pruritus, stranguria due to heat, and odynuria. 3. It can be used for treating carbuncle, swelling, sore, snake and insect bite.
The Opuntia ficus-indica, also known as Longtou, overlord, shenxian palm and Guanyin thorn. Can resist strong illumination, extremely dry and resist day and night temperature difference, and has a long medicinal history in China. The record of Ben Cao gang mu Shi Yi: cactus is bland in taste and cold in nature, and has the functions of promoting qi and blood circulation, relieving pain and swelling, and clearing away heat and toxic materials. In folk, people often use cactus to treat parotitis, mastitis, furuncle, pyogenic infections, burns and scalds, cold injuries, tinea manuum, acne and other diseases. Modern medical research finds that the cactus has the effects of clearing heat, removing toxicity, inhibiting bacteria, resisting inflammation and the like. The fleshy stem of cactus contains rich protein, mineral, cellulose, vitamin C, etc., and also contains rich SOD, flavone, polysaccharide, etc. Specifically, the chemical composition of the cactus stem is: the fresh product contains 85-90% of water, 5-12% of crude protein, 62-76% of digestible dry matter and 2-6% of carbohydrate. The cactus fruit contains high glucose and fructose with a content of 6-8% (dry mass) and low protein content of 3.2-5% (dry mass), and is rich in mineral substances such as potassium, calcium, phosphorus, iron, magnesium and the like and Vc, the cactus introduction is promoted as a variety for vegetables at the beginning of edible cactus introduction, and a series of processed food and beverage such as cactus jam, preserved fruits, cans, beer, yoghourt and the like are developed on the basis. Meanwhile, the cactus has the health-care effects of clearing away heat and toxic materials, expelling toxin, promoting granulation, promoting qi and blood circulation, reducing blood sugar, regulating blood fat and the like, and can promote metabolism and improve human immunity after being taken for a long time. A large number of researches show that cactus has curative effects on various diseases and is widely used for clinically treating stomachache, dysentery, hemorrhoidal bleeding, cough, diabetes and the like in China.
Radix Glycyrrhizae is also named as Mel, radix Glycyrrhizae, GUOLAO, MEICAO, HEIGEN, LINGTONG, herba Hyssopus officinalis, radix Stephaniae Japonicae, radix Glycyrrhizae, and radix Glycyrrhizae Pratentis. It is neutral in nature and flavor, mild in nature and sweet in taste. They enter heart, stomach, spleen and lung meridians. Has the effects of invigorating spleen, replenishing qi, relieving cough, eliminating phlegm, relieving spasm, relieving pain, and regulating drug properties. They belong to qi tonics classified under deficiency tonics. Clinical application, oral administration: decocting 2-6 g in water, small in dosage for harmonizing the effect, slightly larger in dosage as main drug, and about 10 g in dosage; 30-60 g can be used for rescuing poisoning. Stir-baked for tonifying herbs and unprocessed for clearing and purging herbs. External application: proper amount, decocting, washing and soaking; or by grinding and applying. Treating spleen and stomach weakness, deficiency of middle-warmer energy, cough, asthma, carbuncle, sore, abdominal spasm, pain, relieving drug toxicity, and removing drug toxicity. Unprocessed for clearing heat, and stir-baked for tonifying middle energizer. It is contraindicated for excess syndrome with abdominal distention. Pharmacological research shows that the liquorice has the functions of adrenocortical hormone, anti-inflammation, anti-ulcer, anti-allergic reaction, anti-cancer, anti-bacteria, anti-virus, promoting pancreatic secretion, inhibiting in vitro intestines, regulating immune function, relieving cough, eliminating phlegm, resisting mutation, detoxifying, resisting oxidation, protecting the functions of the ear and the vestibule, promoting urination, protecting the liver, preventing arteriosclerosis, resisting cerebral ischemia, preventing diabetic complications and the like. The chemical components of the product mainly comprise liquiritin, glycyrrhizic acid, glycyrrhizin, syringene oxide, glycyrrhetin, 18 alpha-hydroxy glycyrrhetinic acid, isoglycyrrhetinic acid, glycyrrhetinic essence, formononetin, neolicochalcone D, glabrene aglycone, isolicoflavonol, triterpenoid saponin, coumarin and the like.
Radix Ophiopogonis, ophiopogon japonicus, radix Stephaniae Tetrandrae, and Limonitum. It is slightly cold in nature, sweet and slightly bitter in taste. They enter heart, lung and stomach meridians. Has the effects of nourishing yin, promoting the production of body fluid, moistening lung and clearing away heart-fire. They belong to yin tonics classified under deficiency tonics. Pharmacological research, which has the function of protecting the cardiovascular system; enhancing hypoxia tolerance and prolonging the survival time of hypoxia under normal pressure; enhancing immune function; reducing blood sugar; delaying aging; inhibiting gastrointestinal propulsion; and (4) resisting bacteria. The radix ophiopogonis is a good medicine for nourishing yin and moistening lung, and has a good effect of reducing blood sugar in recent years; in clinical application, the heart strengthening effect is stable and good. Experiments also prove that the water-soluble polysaccharide in the dwarf lilyturf tuber has the functions of resisting anoxia and promoting immunity. Chemical components containing multiple steroid saponins, wherein the ophiopogonin A has the highest content, and the ophiopogonin B has the highest content; in addition, it contains many homoisoflavonoids. 5 flavonoid compounds are also separated and identified from the Zhejiang dwarf lilyturf tuber. In addition, it also contains ophiopogonone A, ruscogenin, diosgenin, ophiopogonflavanone, alpha-patchoulene, ethyl palmitate, oleanolic acid, etc. Herba Portulacae is also called as melon seed, sour and herba Otteliae Alismoidis. The nature, flavor and meridian tropism, the taste is sour and the nature is cold. It enters large intestine meridian and liver meridian. Has the functions of clearing away heat and toxic material, cooling blood and stopping bleeding. Belongs to heat-clearing herbs and heat-clearing and toxicity-removing herbs. The clinical application dosage is 9 to 15 grams, and the decoction is taken; the dosage of the fresh product is 30-60 g. Proper amount of the powder is pounded and applied to the affected part. It can be used for treating enteritis, bacillary dysentery, furuncle, toxic swelling, snake and insect bite, hemorrhoid with swelling and pain, eczema, erysipelas, snake and insect bite, hematochezia, hemorrhoid with blood, metrorrhagia, acute dermatitis, subacute dermatitis, herpes zoster, puerperal hemorrhage, functional facial hemorrhage, appendicitis, and ancylostomiasis. Pharmacological research, which has the effect of uterine contraction; affect the cardiovascular and respiratory systems; the Chinese medicinal decoction has biphasic action on skeletal muscle, so that the contraction tension, amplitude and frequency of small intestine are increased, but the decoction is also reported to have an inhibiting effect on guinea pig isolated small intestine; the antibacterial effect is achieved; has cholesterol lowering effect. Can promote the normalization of epithelial cell function and the healing of ulcer. Has diuretic effect. The alcohol extract or the water decoction has obvious inhibition effect on various dysentery bacilli; the composition also has an inhibiting effect on pathogenic dermatophytes such as escherichia coli, typhoid bacillus, staphylococcus aureus, dorsalis parvum and the like, and can generate drug resistance on dysentery bacillus; it also has the effects of promoting ulcer healing, contracting blood vessel, and regulating blood lipid. The chemical components mainly comprise vitamins, organic acids, amino acids, saccharides, fatty acids, flavonoids, trace elements, mucoid, alanine, betanin, isobetanin, norepinephrine and the like.
Selaginella tamariscina, another name is: one grab, tiger paw, perennial grass, ten thousand years pine, etc. Pungent and mild in nature and flavor. The book Jing: "pungent flavor, warm. "2" other records: "sweet, mild and cold, and non-toxic. "3" materia Medica of this materia Medica: unprocessed, pungent and neutral; moxibustion is pungent and warm. "4" Guangxi Zhi Zhong Yao Zhi (TCM journal in Guangxi): "bland and slightly astringent taste, slightly cold in nature. "entering the meridian" in Ben Cao Jing Shu "(Ben Cao Jing Shu): "enter the blood system of foot jueyin and shaoyin. "function, unprocessed is breaking blood, stir-baked to stop bleeding. For indications, the raw one is used for amenorrhea, abdominal mass, traumatic injury, abdominal pain and asthma; stir-baked into charcoal is indicated for hematemesis, hemafecia, hematuria and rectocele. 1. For abdominal pain, amenorrhea and obstruction in the abdomen, it is indicated for blood stasis, pain and pain due to blood stasis, pungent and warm flavor of Selaginella tamariscina, mild and warm nature, and pungent and warm nature. 2. For blood-stasis syndrome, it is pungent and warm with pungent and warm natured herbs, and can dispel stasis and alleviate pain, so it is indicated for hematemesis, hemafecia, hematuria, traumatic injuries and metrorrhagia and metrostaxis. 3. For relieving cough and resolving phlegm, it is pungent and slightly warm in flavor, it is the lung meridian at the upper part, warms lung to dispel cold, relieves cough and resolves phlegm. Pathogenic wind-cold attacking the lung, lung qi failing to disperse and fluids failing to distribute, manifested as cough, expectoration, thin and white sputum, nasal obstruction, clear nasal discharge, itching and heavy throat, headache, fever, aversion to cold, aversion to wind, soreness of joints, thin and white tongue coating, and superficial, tense or slow pulse. For treatment, it is indicated for dispelling wind and cold, dispersing lung qi and nourishing gold, relieving cough and resolving phlegm. It is indicated for its action. 4. Activating meridians and collaterals, as well as activating blood and promoting qi circulation, and dredging meridians and collaterals, selaginella tamariscina Lingzi are good at treating flaccidity. The weak fingers are not used, the weak limbs are not needed, and the frown fingers are weak. For impotence, it is an ancient practice to get yangming, but it is still a blood stasis after a long period of treatment, failing to nourish the collaterals, numbness, and even withering of the tendons and vessels. The administration of qi-moving and blood-activating herbs can bring new and old feeling. (1) The book Jing: "governing the five zang organs with pathogenic qi, cold-middle energizer heat pain of female yin, abdominal mass, blood block and sterility. "(2) bibliography: "relieving cough and dyspnea", treating rectocele, stranguria and nodulation, wind-dizziness in head, atrophy-flaccidity, strengthening yin and replenishing essence. "(3) treatise on drug Property: "treat menorrhagia. "(4) Rihuazi Ben Cao (Japanese: "Zhen Xin, excepting quite facial complexion, headache wind, warm water and viscera. Unprocessed is used to break blood and stir-baked is used to stop bleeding. "(5) Classification of herb Properties": for traumatic injury, move qi, stir-bake black and stop hematemesis. "(6) modern practical Chinese medicine": "treat hematuria. (7) Anhui medicinal materials: "externally applied can treat knife wound. "(8) Nanning City records of drugs: for heat intestinal hemorrhage and metrorrhagia, it is used externally to heal bone. ", a
Eucalyptus leaves are called Eucalyptus leaves (modern practical traditional Chinese medicine) and Eucalyptus globulus leaves (Guangxi Chinese medicine). Bitter and pungent in flavor and cool in nature. (1) Guangxi Chinese medicine J: bitter taste and warm nature. And (2) in the journal of Sichuan Chinese herbs: "warm in nature, bitter in taste, non-toxic. (3) Yunnan Chinese herbal medicine: bitter, pungent and cool. The Chinese medicinal composition has the main functions of treating cold, influenza, dysentery, enteritis, arthralgia, cystitis, scald, mange, erysipelas, neurodermatitis, eczema and carbuncle sore pyogenic infections.
The capsicum is another name, capsicum, spicy eggplant, spicy tiger, preserved eggplant, capsicum, peppers and big peppers. The nature and flavor enter meridians, heat property and pungent taste. It enters heart and spleen meridians. Has the functions of warming the middle-jiao to dispel cold, stimulating appetite and promoting digestion. It belongs to interior-warming herbs. Pharmacological research shows that the product has analgesic and anti-inflammatory effects. Effects on the digestive system: the hot pepper decoction is drenched to promote the healing of the acute and chronic gastric mucosa injury of the rat caused by hydrochloric acid and acetic acid; oral administration of red dry pepper powder capsule promotes ulcer healing of gastric ulcer patients, and pepper can enhance the contraction movement of guinea pig isolated gallbladder, and its effect can be weakened by indomethacin but not blocked by atropine. Effects on the cardiovascular system: the capsaicin can improve myocardial function of rat reperfusion injury, inhibit creatine kinase release, and increase plasma concentration of calcitonin gene related peptide. Other functions are as follows: capsaicin selectively exhausts neuropeptide substances at the tail end of sensory nerve, reduces sensitivity to chemical substances, and has desensitization effect on nasal mucosa of human and animals. Capsaicin treats the unilateral nasal mucosa of a guinea pig, reduces ipsilateral secretion, completely blocks contralateral secretion reaction, has the functions of eliminating axonal reaction and nasal secretion caused by central reflex, and reduces the sensitivity of sensory nerves to noxious stimulation. Chemical components, wherein the pepper fruit contains capsaicin components, also contains various low-boiling point and high-boiling point volatile carboxyls, and also contains beta-carotene, lutein, zeaxanthin, capsorubin, cordierite, solanine, solanidine, citric acid, tartaric acid, malic acid and the like, and the seed contains solanine, solanidine, 4-alpha-methyl-5-alpha-cholest-8-ene-3-beta-ol cycloartenol, 24-methylene cycloartenol, lupeol and the like.
The main effective components of kava pepper are Kavalactones (Kavalactones), methysticin, kawain (Kawain), etc., can bidirectionally regulate neurotransmitter, has various effects of resisting anxiety and depression, tranquilizing and hypnotizing, local anesthesia, anticonvulsive, etc., and no drug dependence is observed.
Kava pepper was approved by the german federal health administration for the treatment of anxiety as early as 1990, and was incorporated in the united kingdom as the plant pharmacopoeia, the united states as the new edition of the united states pharmacopoeia, and many countries in the united states of europe and america as over-the-counter or prescription drugs. Dihydrokavain and dihydrokavain contained in kava (PipermethoccumFost) have remarkable muscle relaxation effect, and their analgesic effect is superior to aspirin.
Because kava root has natural active substances, the kava root can act on the emotional center of the brain to exert the physiological effect, relax the mind and body, and reduce the pressure, relieve the anxiety, correct the depression and promote the sleep by drinking kava wine, thereby becoming the mental health-care folk prescription of modern people.
In recent years, kava is recommended worldwide as a food supplement. Piper methysticum has been one of the best 20 herbs sold in Germany in 1995. And is also one of the 16 best-selling herbals in the United states. The Kava (Kava, kawx) is popular among folk doctors in the island of south Pacific ocean and is regarded as the "holy medicine", and indigenous residents regard the Kava as the "highest-ranking plant". Hawaii once stipulates that the people steal slips to make death criminals, and is sufficient to see how the plant is important.
From the 19 th century, european and American scientists have proved from chemical, pharmacological, toxicological and clinical studies that kava mainly comprises kavalactone, methysticin, kawain, dihydrokawain and the like, can bidirectionally regulate neurotransmitters, relieve stress, relieve anxiety, overcome depression, relax muscles, eliminate fatigue and relieve insomnia, and has unexpected effects. Slips are then collected in the plant pharmacopoeia, the united states new edition, the united states pharmacopoeia, and many countries in the united states of europe and america classify slips as over-the-counter or prescription drugs.
Kava was approved by the Food and Drug Administration (FDA) as a mental health food in 1992, and the advent of kava in france made the conventional hypnotic almost unquestionable. Kava is used as a health product for relieving mental stress, stabilizing mental balance, and improving sleep in Japan. As early as 1995, american scientists karse and professor mallow presented in coworking "first health" and "natural answers to slips, stress, anxiety and insomnia": imbalance of neurotransmitter is the root of insomnia, and the kava, an herbal medicine capable of regulating neurotransmitter, is a natural answer for solving insomnia problems such as stress, anxiety, depression and the like and psychological problems.
Borneol is a medicine for inducing resuscitation and refreshing mind, clearing heat and relieving pain, belonging to the field of resuscitation drugs.
Preferably, the water in the step (1) is added in an amount of 1500 to 3000 parts by weight, and the water is deionized water, purified water or distilled water.
Preferably, the medicinal materials in the step (1) are soaked in water according to the following components in parts by weight:
15 parts of common andrographis herb, 15 parts of szechuan lovage rhizome, 15 parts of large flower cactus, 15 parts of selaginella tamariscina, 15 parts of liquorice, 15 parts of purslane, 9 parts of kava pepper, 9 parts of eucalyptus leaf, 15 parts of dwarf lilyturf tuber, 1 part of hot pepper and 2 parts of borneol.
Preferably, the soaking time in the step (1) is 30 to 60 minutes.
Preferably, the distillation device in step (2) is a vacuum distillation generator made of stainless steel, enamel or glass.
Preferably, the distillation time in step (2) is 30 to 60 minutes.
Preferably, in the step (3), the humectant is at least one of butanediol, glycerol, polyalcohol or propylene glycol; the small molecule moisturizing lubricant is polyethylene glycol 400 and sodium hyaluronate 1000.
Preferably, in the step (3), the amount of the humectant is 0.5 to 1.5% by weight based on the weight of the distilled extract.
Preferably, the extracting solution of the microalgae in the step (4) is respectively extracted by alcohol and aqueous solution, and the alcohol is distilled off; the mixed solution of the residual microalgae oil-soluble extract and microalgae water-soluble extract is used for the eye drop.
Compared with the prior art, the invention has the advantages that: the microalgae oil-soluble extract is used as an antioxidant for resisting free radicals, macromolecular peroxide is directly combined with parts such as retina, cornea, ciliary muscle and the like, the microalgae water-soluble extract is matched with traditional Chinese medicines, common andrographis herb, ligusticum wallichii, opuntia ficus-indica and selaginella tamariscina are used as monarch medicines, and liquorice, purslane and radix ophiopogonis are used as minister medicines, kava pepper, eucalyptus leaves, hot pepper and borneol as assistants and guides. Because the common andrographis herb has the effects of clearing heat and removing toxicity and dissipating carbuncle swelling, the combination of the common ligusticum, the large flower cactus and the selaginella tamariscina can enhance the effects of clearing liver and improving vision and dissipating the carbuncle swelling, eleven medicaments of monarch, minister, assistant and guide are matched and applied together, the effects are strong, the common andrographis herb is distilled into dew and good in absorption, and the volatilization speed is slowed down by adding a moisturizing agent. Has no side effect, has effects of clearing heat, removing pathogenic fire, removing toxic substance, relieving inflammation, improving eyesight, removing nebula, promoting blood circulation and removing blood stasis, and is suitable for preventing and treating myopia, astigmatism, cataract, glaucoma, keratitis, conjunctivitis, asthenopia, epiphora induced by wind, etc. Has the characteristics of rapid inflammation diminishing, fire removing and instant fatigue eliminating. The practical application proves that the obtained eye drop has good effects on treating myopia, cataract, muscae volitantes, epiphora induced by wind, asthenopia and glaucoma.
Detailed Description
The present invention is described in further detail below with reference to examples.
Example 1, 1800 parts of distilled water (or deionized water) obtained by distillation is used for soaking medicinal materials for 40 minutes, then a stainless steel steam generator is used for low-temperature distillation, the temperature is controlled to be 60-80 ℃, after the temperature of steam reaches 60 ℃, the vacuum degree is-0.2 MPA, distillation is carried out for 40 minutes, the obtained white liquid is pure dew, the pure dew is fast to absorb and volatilize, after cooling, 3 parts of medical glycerin and a small molecule moisturizing lubricant are added, namely polyethylene glycol 400 and sodium hyaluronate 1000 are respectively used for moisturizing, and the medical glycerin is adopted as the best, so that the speed of volatilization is reduced, and the efficacy is enhanced. The weight ratio of the medicinal materials is as follows: 15 parts of common andrographis herb, 15 parts of szechuan lovage rhizome, 15 parts of large flower cactus, 15 parts of selaginella tamariscina, 15 parts of liquorice, 15 parts of purslane, 9 parts of kava pepper, 9 parts of eucalyptus leaf, 15 parts of dwarf lilyturf tuber, 1 part of hot pepper and 2 parts of borneol.
Preparing water-soluble and oil-soluble extracts of dunaliella salina, dissolving 2 parts of dunaliella salina powder by 1000 parts of 95% alcohol, distilling at 50 ℃, extracting for 50 minutes at a vacuum degree of-0.2 MPA, and adding PVP water solution into the liquid after alcohol distillation, wherein the content of PVP is 30%; continuously heating the saline algae mixed solution with PVP in vacuum for 30 min at 50 deg.C to obtain saline algae oil-soluble and water-soluble extraction mixed solution, and measuring carotenoid content for use.
Mixing the above traditional Chinese medicine distilled mixed solution added with humectant with oil soluble extract and water soluble extract of Dunaliella salina, and making into eye drop.
Example 2, 1800 parts of distilled water obtained by distillation is used for soaking medicinal materials for 40 minutes, then distilled at low temperature by using a stainless steel steam generator, the temperature is controlled to be 60-80 ℃, the vacuum degree is-0.2 MPA after the temperature of steam reaches 60 ℃, and the white liquid obtained by distillation is pure dew, because the pure dew is fast to absorb and volatilize, after cooling, 3 parts of medical glycerin and a micromolecule moisturizing lubricant are added, namely polyethylene glycol 400 and sodium hyaluronate 1000 respectively for moisturizing, and the medical glycerin is adopted as the best, so that the volatilization is reduced, and the efficacy is enhanced. The weight ratio of the medicinal materials is as follows: 15 parts of common andrographis herb, 15 parts of szechuan lovage rhizome, 15 parts of large flower cactus, 15 parts of selaginella tamariscina, 15 parts of liquorice, 15 parts of purslane, 9 parts of kava pepper, 9 parts of eucalyptus leaf, 15 parts of dwarf lilyturf tuber, 1 part of hot pepper and 2 parts of borneol.
A water-diffusible dry powder of carotenoid (synthetic) is a technological process mode, which is a technology that the carotenoid (synthetic) is added with emulsifier modified starch and the like to make fat-soluble carotenoid (synthetic) to be diffused in water, the content of carotenoid (synthetic) in the water-diffusible dry powder of carotenoid (synthetic) is 1% -20% of the carotenoid (synthetic) content, and the concentration of carotenoid (synthetic) in the eye drops is 0.01-100ppm.
Mixing the above traditional Chinese medicine distilled mixed solution added with humectant with water-dispersible carotenoid (synthetic type) dry powder (synthetic type commercially available, non-microalgae extract) deionized water solution, and making into eye drop.
Example 3, 1800 parts of distilled water obtained by distillation is used for soaking medicinal materials for 40 minutes, then a stainless steel steam generator is used for low-temperature distillation, the temperature is controlled to be 60-80 ℃, the vacuum degree is-0.2 MPA after the temperature of steam reaches 60 ℃, the distillation lasts 40 minutes, the obtained white liquid is hydrolat, because the hydrolat is fast to absorb and volatilize, after cooling, 3 parts of medical glycerin and a micromolecular moisturizing lubricant are added, namely polyethylene glycol 400 and 1000 parts of sodium hyaluronate are respectively used for moisturizing, and the medical glycerin is adopted as the best, so that the volatilization is reduced, and the efficacy is enhanced. The weight ratio of the medicinal materials is as follows: 15 parts of common andrographis herb, 15 parts of szechuan lovage rhizome, 15 parts of large flower cactus, 15 parts of selaginella tamariscina, 15 parts of liquorice, 15 parts of purslane, 9 parts of kava pepper, 9 parts of eucalyptus leaf, 15 parts of dwarf lilyturf tuber, 1 part of hot pepper and 2 parts of borneol. Preparing oil and water extracts of chlorella, dissolving 2 parts of chlorella powder in 1000 parts of 95% alcohol, distilling at 50 ℃, extracting for 50 minutes at a vacuum degree of-0.2 MPA, adding PVP (polyvinyl pyrrolidone) water solution into the liquid after alcohol distillation, continuously heating chlorella mixed solution added with PVP at 20% in vacuum for 30 minutes at 50 ℃; measuring the content for later use. The concentration in the eye drops is 0.01-100ppm; carotenoid content of 1-10%, and carotenoid concentration in eye drops of 0.01-100ppm.
Adding the above traditional Chinese medicine distilled mixed solution added with humectant, oil soluble extract of Chlorella vulgaris and water soluble extract mixed solution into deionized water solution, mixing, and making into eye drop.
Example 4, 1800 parts of distilled water obtained by distillation is used for soaking medicinal materials for 40 minutes, then distilled at a low temperature by using a stainless steel steam hair generator, the temperature is controlled to be 60-80 ℃, the vacuum degree is-0.2 MPA after the temperature of steam reaches 60 ℃, and the white liquid obtained by distillation is pure dew, because the pure dew is fast to absorb and volatilize, after cooling, 3 parts of medical glycerin and a micromolecule moisturizing lubricant are added, namely polyethylene glycol 400 and sodium hyaluronate 1000 are respectively used for moisturizing, and the medical glycerin is used as the best, so that the volatilization is reduced, and the efficacy is enhanced. The weight ratio of the medicinal materials is as follows: 15 parts of common andrographis herb, 15 parts of szechuan lovage rhizome, 15 parts of large flower cactus, 15 parts of selaginella tamariscina, 15 parts of liquorice, 15 parts of purslane, 9 parts of kava pepper, 9 parts of eucalyptus leaf, 15 parts of dwarf lilyturf tuber, 1 part of hot pepper and 2 parts of borneol. Preparing a water-soluble and oil-soluble extract of haematococcus pluvialis, dissolving 2 parts of haematococcus pluvialis powder by using 1000 parts of 95% alcohol, distilling at 50 ℃, extracting for 50 minutes at a vacuum degree of-0.2 MPA, adding a PVP (polyvinyl pyrrolidone) aqueous solution into the liquid after alcohol distillation, wherein the PVP content is 10%, and continuously heating the mixed solution of the haematococcus pluvialis added with PVP for 30 minutes in vacuum at 50 ℃; measuring the content for later use. The concentration in the eye drops is 0.01-100ppm; 1-10% carotenoid, and the concentration of carotenoid in the eye drop is 0.01-100ppm.
Adding the traditional Chinese medicine distillation mixed liquor added with the humectant and the mixed liquor of the haematococcus pluvialis oil-soluble extract and the water-soluble extract into deionized water solution for mixing, and preparing the special eye drop.
Example 5, 1800 parts of distilled water obtained by distillation is used for soaking medicinal materials for 40 minutes, then distilled at low temperature by using a stainless steel steam generator, the temperature is controlled to be 60-80 ℃, the vacuum degree is-0.2 MPA after the temperature of steam reaches 60 ℃, and the white liquid obtained by distillation is pure dew, because the pure dew is fast to absorb and volatilize, after cooling, 3 parts of medical glycerin and a micromolecule moisturizing lubricant are added, namely polyethylene glycol 400 and sodium hyaluronate 1000 are respectively used for moisturizing, and the medical glycerin is adopted as the best, so that the volatilization is reduced, and the efficacy is enhanced. The weight ratio of the medicinal materials is as follows: 15 parts of common andrographis herb, 15 parts of szechuan lovage rhizome, 15 parts of large flower cactus, 15 parts of selaginella tamariscina, 15 parts of liquorice, 15 parts of purslane, 9 parts of kava pepper, 9 parts of eucalyptus leaf, 15 parts of dwarf lilyturf tuber, 1 part of hot pepper and 2 parts of borneol. Preparing oil-soluble and water-soluble spirulina extract, dissolving 2 parts of spirulina powder in 1000 parts of 95% alcohol, distilling at 50 ℃, with a vacuum degree of-0.2 MPA, extracting for 30 minutes, adding PVP water solution into the liquid after alcohol distillation, with a PVP content of 40%, and continuously heating the spirulina mixed liquid added with PVP in vacuum for 30 minutes at 50 ℃; measuring the carotenoid content for later use. The concentration in the eye drops is 0.01-100ppm; the content of carotenoid, phycocyanin and chlorophyll ester is 1% -10%, and the concentration of carotenoid, phycocyanin and chlorophyll ester in the eye drops is 0.01-100ppm. Adding the above traditional Chinese medicine distilled mixed solution added with humectant and mixed solution of oil-soluble and water-soluble extract of Spirulina into deionized water solution, mixing, and making into eye drop.
In order to verify the application effect of the invention, the inventor carries out clinical trials in which:
1. 60 pseudomyopia groups are selected for use, and after the pseudomyopia is used for three months, 58 cases of eyes are improved by 0.2 degrees, and 40 cases of eyes are improved by 0.4 degrees or more.
2. After the cataract extraction liquid is used for 60 cataract people, 58 cataract people have obvious improvement after the cataract extraction liquid is used for three months, 59 cataract people with 0.4 degree of binocular elevation, and the rest cataract extraction liquid also has certain improvement effect.
The eyedrops obtained in example 1 are applied to the eyes of a plurality of patients, as follows:
application example 1, zhao lady, people in inner Mongolia Guke stone City, age 76 years old, self-worried that eyes are dry and lacked to see clearly what is unclear, no effect can be seen in eye drops purchased in pharmacy, multiple treatments in hospitals in inner Mongolia Guke stone City are ineffective, right eye cataract is confirmed, left eye astigmatism plus muscae volitantes, the eye drops in the embodiment are adhered to be sprayed for three times every day for 30 days, one bottle of 10ml is basically used up, eyes are bright, lacrimation is not so good, and foreign matters are not existed; the second bottle is continuously used for 30 days, the left eye can clearly see the objects without deformation, dryness and lacrimation, the right eye can clearly see the objects for 30 to 60 minutes, and at present, the second bottle is continuously used for consolidation and is sprayed twice every day. The naked eye vision of the left eye is recovered to 0.8 from 0.3 before use, and the naked eye vision of the right eye is recovered to 0.5 from 0.1.
This example 2 obtains eye drops for application to the eyes of a plurality of patients, as exemplified below
Application example 2, wen somewhere, man, 75 years old, call for inner Mongolia and Haoyeshan. After more than ten years of cataract, the vision of the left eye is reduced to 0.1, and the vision of the right eye is reduced to 0.2; all objects seen from the above are modified, and mosquitoes are also present. Doctors recommend operative treatment, but the inventor decides that conservative treatment does not carry out operative treatment, but does not improve the treatment, the eye drops in the example 2 are used for more than one year, mosquitoes in front of eyes are not basically used, and the eye drops are sprayed every day and are clear, cool and moist. The vision of both eyes is obviously recovered. The left eye vision is restored to 0.3 after three months, the right eye is restored to 0.5, and the television can be watched at night (before the television is listened).
This example 3 provides eye drops for application to the eyes of a plurality of patients, as exemplified below
Application example 3, the Lu women, the Shanxi province of the family, the Chang Zhi City, the chronic keratitis, all the eye drops suitable for the keratitis in the pharmacy are used, the effect is not ideal, the doctor recommends to do the operation, the doctor introduces the spraying of the traditional Chinese medicine eye drops in the embodiment 3, the doctor insists on using the eye drops for nearly one month, feels that the eyes are comfortable, especially the eyesight is improved, feels that the eyes are bright after spraying, the doctor goes to the hospital to see, says that the keratitis is sixty percent better, and the spraying continues for one month every day, so the eyes are better. After three months of examination, the eyes recovered to normal and the naked eye vision improved by 0.4.
This example 4 obtains eye drops for application to the eyes of a plurality of patients, as exemplified below
In application example 4, a certain populus, living in the region of the sunny province of Beijing, anzhenlie, has a common hair disease with tearing against wind, and cataract lasts for 10 years, and the eye drop of example 4 is introduced by friends and is sprayed on the body at any time, so that the eyes feel not tearing against wind, and the eyesight of the eyes is 0.5, which is 0.3 higher than that of the former.
This example 5 provides eye drops for multiple patients, as listed below
Application example 5, a certain plum is a male, 21 years old, and a person in small olive town in Zhongshan city, guangdong province, 14 years old can find myopia, more than 350 degrees, and the glasses are worn, so that the parents feel special care because of no inheritance in the family, and the hospital has checked that no special diseases exist, and recommends to use the eyedrops in the example 5 by people, the person sprays for about five times every day, the massager is used after spraying to massage the eyes for 18 minutes, and then the eyes are sprayed for several times, so that the eyes are particularly comfortable and insist to use, so far, more than half a year is used, the degree of the left eye glasses is reduced to 200 degrees, the degree of the right eye glasses is reduced to 250 degrees, and the person just starts to have little discomfort, and the eyedrops really play a role in treating myopia after being matched with the glasses after going to the hospital for optometry.
Claims (10)
1. A medicine for preventing and treating cataract and myopia and a preparation method thereof are characterized by comprising the following steps:
(1) soaking the medicinal materials, wherein the medicinal materials with the following components and weight ratio are soaked by 1500-3000 parts of water by weight:
1 to 20 parts of ligusticum chuanxiong hort, 10 to 20 parts of common andrographis herb, 6 to 15 parts of large flower cactus, 6 to 15 parts of liquorice, 10 to 20 parts of dwarf lilyturf tuber, 6 to 15 parts of purslane, 6 to 15 parts of selaginella tamariscina, 1 to 20 parts of hot pepper, 1 to 20 parts of eucalyptus leaf, 1 to 20 parts of kava pepper and 0.1 to 3 parts of borneol. (2) Vacuum distilling the above materials with a distilling device at 60-80 deg.C to obtain white distilled extract. (3) Adding 3-9 parts of humectant, 1 part of each of polyethylene glycol 400 and sodium hyaluronate 1000 and 1 part of microalgae carotene solution into the white distilled extract to obtain eye drop. (4) Preparing water-soluble and oil-soluble extracts of microalgae, dissolving 2 parts of microalgae powder by 1000 parts of 95% alcohol, distilling at 50 ℃, and adding PVP aqueous solution into the liquid after alcohol distillation, wherein the content of PVP is 10% -50%; and continuously heating the microalgae mixed solution added with PVP in vacuum for 30 minutes at 50 ℃ to obtain microalgae oil-soluble and water-soluble extract mixed solution, and measuring the carotenoid content for later use. The eye drop is prepared by measuring the contents of carotenoid, phycocyanin and chlorophyll ester, blending to below 100ppm, mixing with the extractive solution of Chinese medicinal materials added with humectant, and bottling. (5) The aqueous solution of the microalgae oil-soluble extract can also be prepared by mixing water-soluble diffusion dry powder of synthesized carotenoid, chlorophyll ester, phycocyanin ester and glyceric acid ester and deionized water; mixing the prepared traditional Chinese medicine extract with humectant to prepare the special eye drop.
The microalgae comprise: dunaliella, chlorella, haematococcus pluvialis, and Spirulina. These microalgae contain a large amount of oil-soluble antioxidants including carotenoids, phycocyanins, chlorophyll esters.
2. The method according to claim 1, wherein the water in the step (1) is added in an amount of 1500 to 3000 parts by weight, and the water is deionized water, purified water or distilled water.
3. The preparation method according to claim 1, wherein the medicinal materials in the step (1) are prepared by soaking the following components in parts by weight in water: 1 to 20 portions of Szechuan lovage rhizome, 10 to 20 portions of common andrographis herb, 6 to 15 portions of large flower cactus, 6 to 15 portions of liquorice, 10 to 20 portions of dwarf lilyturf tuber, 6 to 15 portions of purslane, 6 to 15 portions of selaginella tamariscina, 1 to 20 portions of hot pepper, 1 to 20 portions of eucalyptus leaf, 1 to 20 portions of kava pepper and 0.1 to 3 portions of borneol.
4. The method according to claim 1, wherein the soaking time in the step (1) is 30 to 60 minutes.
5. The method according to claim 1, wherein the distillation apparatus in step (2) is a vacuum distillation generator made of stainless steel, enamel or glass.
6. The production method according to claim 1, wherein the distillation time in the step (2) is 30 to 60 minutes.
7. The method according to claim 1, wherein the humectant in the step (3) is at least one of butylene glycol, glycerin, polyhydric alcohol, or propylene glycol; the small-molecule moisturizing lubricant is polyethylene glycol 400 and sodium hyaluronate 1000.
8. The method according to claim 1, wherein the humectant is added in an amount of 0.5 to 1.5% by weight based on the weight of the distilled extract in the step (3).
9. The method according to claim 1, wherein the microalgae extract in step (4) is: mixing oil-soluble extract of microalgae with water-soluble extract of microalgae, wherein the solvent used in the oil-soluble extract is alcohol (or other organic solvent), and the extract is carotenoid, phycocyanin ester, chlorophyll ester, and glycerate; the extraction time is vacuum heating for 30 minutes, the temperature is 50 ℃, and the vacuum degree is-2 MPA; the microalgae comprise: dunaliella salina, chlorella vulgaris, haematococcus pluvialis, and Spirulina, wherein the microalgae contains large amount of oil soluble antioxidant including carotenoid, phycocyanin, chlorophyll ester, and glycerol oleate; similar synthetics of these microalgae antioxidants are also possible.
10. The method according to claim 1, wherein the mixed solution of the water-soluble solution of the oil-soluble extract of microalgae in step (5) is further prepared by mixing water-soluble diffusion dry powder of synthesized carotenoid, chlorophyll ester, phycocyanin ester, and glyceric acid ester with deionized water; the eye drop is prepared by matching the prepared traditional Chinese medicine extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110606014.8A CN115429846A (en) | 2021-06-01 | 2021-06-01 | Medicine for preventing and treating cataract and myopia and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110606014.8A CN115429846A (en) | 2021-06-01 | 2021-06-01 | Medicine for preventing and treating cataract and myopia and its preparing method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115429846A true CN115429846A (en) | 2022-12-06 |
Family
ID=84271973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110606014.8A Pending CN115429846A (en) | 2021-06-01 | 2021-06-01 | Medicine for preventing and treating cataract and myopia and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115429846A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112353883A (en) * | 2020-11-20 | 2021-02-12 | 刘圆霖 | Preparation method of eye drop for treating myopia muscae volitantes |
-
2021
- 2021-06-01 CN CN202110606014.8A patent/CN115429846A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112353883A (en) * | 2020-11-20 | 2021-02-12 | 刘圆霖 | Preparation method of eye drop for treating myopia muscae volitantes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105233010A (en) | Wine capable of invigorating kidney and strengthening Yang and making method thereof | |
CN110354204B (en) | Composition with eyesight improving effect and preparation and application methods thereof | |
CN102657278A (en) | Asparagus healthcare tea | |
CN103859375A (en) | Formula and preparation method of life cultivation and health preservation food helpful for enhancing immunity | |
CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
CN103041042B (en) | Tibetan medicine composition and application of composition in anti-off hair products | |
CN105213941A (en) | A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof | |
CN108324921B (en) | A pharmaceutical composition with cyst removing and gastric mucosa protecting effects, and its preparation method | |
CN105249440A (en) | Donkey-hide gelatin cake | |
KR101999675B1 (en) | Herbal composition for the prevention and treatment of coronary heart disease | |
CN103859373A (en) | Formula and preparation method of life cultivation and health preservation food helpful for preserving health during menstrual period | |
CN109549958A (en) | The composition and preparation method thereof for treating steroid dependent dermatitis | |
CN107823293A (en) | Treat Yao nationality medicine external pulvis of canker sore and preparation method thereof | |
CN115429846A (en) | Medicine for preventing and treating cataract and myopia and its preparing method | |
CN113662068A (en) | Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea | |
CN102846113A (en) | Mulberry leaf health care pillow core and preparation method thereof | |
CN106822660A (en) | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease | |
CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
CN102940753B (en) | Pills for treating glaucoma and preparation method | |
CN114748583A (en) | Traditional Chinese medicine liquor for nourishing and preserving health | |
CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
CN110859912A (en) | Traditional Chinese medicine composition for prostatitis and preparation method and application thereof | |
CN113750182A (en) | Medicinal and edible composition for preventing and treating gout as well as preparation method and application thereof | |
CN106668332B (en) | Passion fruit buccal tablet and preparation method thereof | |
CN104762178A (en) | Taxus chinensis chronic gout-dispelling nectar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Xie Kun Document name: Notice of Completing and Correcting Procedures |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Xie Kun Document name: Review Business Special Letter |